Clinical Trial Update: A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

View source ↗

Summary

This update notes that the CS Reducer trial for symptomatic heart failure with preserved ejection fraction and coronary microvascular dysfunction is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Dysfunction
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• CS Reducer

Snippet

Sponsor: Mayo Clinic | Conditions: Heart Failure With Preserved Ejection Fraction, Coronary Microvascular Dysfunction | Status: RECRUITING